Clinical Trial Update: Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of tyrosine adsorbed grass pollen allergoid with MPL in patients with grass pollen hypersensitivity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Hypersensitivity

Drugs mentioned

• Tyrosine adsorbed grass pollen allergoid with MPL

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 2 | Status: COMPLETED